Monitoring Needs in Intensive Care Units Dramatically Spikes as COVID-19 Infections & Hospitalization Rates Increase

NEW YORK, Nov. 19, 2020 /PRNewswire/ --
Monitoring Needs in Intensive Care Units Dramatically Spikes as COVID-19 Infections & Hospitalization Rates Increase. Blood Gas and Electrolyte Analyzers Demand Spikes by 10.1%


Read the full report: https://www.reportlinker.com/p05817884/?utm_source=PRN


The global market for Blood Gas and Electrolyte Analyzers is expected to spike by 10.1% in the year 2020 and continue to grow to reach US$1 billion by the year 2027, trailing a post COVID-19 CAGR of 5.1% over the analysis period 2020 through 2027. The increase in COVID-19 hospitalizations is more than counterbalancing the decline in non-COVID-19 ICU admissions due to surgery cancellations and postponement. Hospitalization rates remain high in the age group of 60 to 79 years. The overwhelming caseload of COVID-19 patients globally has burdened the healthcare system and created a pressing demand for diagnostic solutions and medical interventions. For COVID-19 patients that display signs of respiratory distress, or who are admitted in ICU units and are on ventilation support, blood gas testing is considered crucial. The assessment of damage caused due to COVID-19 in patients requires several diagnostic tests and medical interventions. While reverse transcription-polymerase chain reaction (RT-PCR) tests remain gold standard to diagnose the infection, critical care tests including blood gas and electrolyte analyzers are gaining attention among the medical fraternity for effective treatment decisions. Arterial blood gas analyzers offer measurement related to acid-base status and blood oxygenation along with gas exchange efficiency of the lungs. The device gains relevance in helping medical professionals effectively manage COVID-19 patients while making relevant treatment decisions.

Arterial blood gas is a common test used for measuring blood acid and oxygenation levels along with diagnosing respiratory or renal conditions. Respiratory systems of patients are critically damaged by COVID-19 infection are hence they are unable to move oxygen inside the body and remove carbon dioxide. Also acid-base imbalance is common in patients suffering from severe viral infections, such as COVID-19. Hence accurate measurement of blood gas results is important to manage the progression of the disease in patients to assess their critical condition. The requirement to monitor these patients is driving volume demand for blood gas and electrolyte analyzers in hospitals. Blood gas and electrolyte analyzers measure various parameters from blood samples, such as pH, pCO2 and pO2, electrolytes, and metabolites. The pH value of blood and serum indicates the balance between the blood, renal, and lung systems, while the pCO2 value is used to assess the amount of carbon dioxide eliminated from the body, and the pO2 value of arterial blood indicates oxygen absorbance in the lungs. Depending on patient care scenario, physicians are relying on sophisticated critical care testing devices such as cartridge combinations of electrolytes and gases. The increasing use of these systems for point-of-care testing in laboratories and acute care venues such as COVID-19 emergency rooms, intensive care units and ambulances is boosting demand for blood gas and electrolyte analyzers.

To leverage the opportunities for growth, several companies are launching advanced devices. Radiometer, a major provider of blood gas testing solutions, is offering ABL800 Flex blood gas analyzers for automated sampling and high throughput. Instrumentation Laboratory is serving healthcare needs with its advanced Gem Premier 5000 blood gas testing platform that offers automated quality with each sample. The device quickly identifies and automatically rectifies errors. While Roche Diagnostics and Nova Biomedical are offering cobas b 123 point-of-care and StatProfile pHOx Ultra systems, respectively, for enhanced throughput. On the other hand, Abbott is riding high on the popularity of its handheld i-Stat 1 blood analyzer solution for critical care that allows menu expansion for including various chemistries, electrolyte, blood gases, hematology, coagulation and cardiac markers. Epoc, a handheld wireless device from Siemens Healthineers, supports exhaustive blood analysis testing at bedside. These sophisticated solutions from vendors are anticipated to improve patient care by enabling physicians to make informed and better treatment decisions. Siemens Healthineers has secured US FDA approval for its advanced RapidPoint 500e blood gas analyzer for critical care testing. The device is intended measure electrolyte, blood gas, Co-oximetry, metabolite and neonatal bilirubin levels to aid diagnosis and monitoring of critically-ill patients in emergency rooms, intensive care units and operating rooms. Monitoring of respiratory conditions in point-of-care settings involves the use of blood gas testing devices capable of offering accurate and fast results while improving workflow efficiency. The analyzer is built on Integri-sense technology that allows automated functional checks for accurate results at point-of-care settings. In addition, RAPIDPoint 500e blood gas analyzer seamlessly integrates into hospital networks using the company's Point of Care Ecosystem for remote, convenient management of devices and operators at multiple sites. The new device holds a critical role in response efforts towards COVID-19 that depend heavily on blood gas testing for patient monitoring and management.

Competitors identified in this market include, among others,

• Abbott Point of Care, Inc.
• Convergent Technologies GmbH & Co. KG
• DALKO Diagnostics
• EDAN Instruments, Inc.
• Erba Mannheim
• F. Hoffmann-La Roche AG
• Instrumentation Laboratory, a Werfen Company
• Medica Corporation
• OPTI Medical Systems, Inc.
• Radiometer Medical ApS
• Siemens AG
• Tecom Analytical Systems

Read the full report: https://www.reportlinker.com/p05817884/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
Impact of Covid-19 and a Looming Global Recession II-1
Life-Saving Interventions for COVID-19 Patients Drive
Importance of Blood Gas & Electrolyte Analyzers II-1
Exhibit 1: Percentage of People with COVID-19 Admitted to the
ICU in the United States from January 22 to May 30, 2020, by
Age II-2
Industry Witnesses Inflow of Sophisticated Solutions II-3
Blood Gas and Electrolyte Analyzers: An Introduction II-4
Types of Analyzers II-5
Fundamentals of Blood Gases and Blood Gas Testing II-6
Blood Gas Parameters and their Significance II-7
Outlook II-7
Point-of-Care Analyzers Gain Significance II-9
Hurdles to Overcome II-9
Competition II-10
Exhibit 2: Market Share of Leading Players in Global Blood Gas
and Electrolyte Analyzers Market: 2019 II-10
Recent Industry Activity II-11
World Brands II-12

2. FOCUS ON SELECT PLAYERS II-13

3. MARKET TRENDS & DRIVERS II-14
Decentralized Testing Gains Traction II-14
Technology Advancements: Cornerstone for Market Growth II-14
Select New Devices II-15
Advanced Sensors Give Way to Modern Devices II-16
Blood Gas Testing Becomes Commonplace in Critical Care II-16
Benchtop Makers Cash in on the Lucrative POC Market II-17
Advanced Solutions for Point-of-Care & Critical Care Settings II-17
Integration with LIS and EMR Widens Functionality II-18
Miniaturised Blood Gas Analysers Gain Traction II-18
Increasing Prevalence of Chronic Disorders and Patient
admissions Fuels Market Growth II-19
Assessment of Various Conditions Based on Blood Gas Testing II-20
Alarming Levels of Diabetes Incidence Worldwide Drives Demand II-20
Exhibit 3: World Diabetes and Population Statistics (2019, 2030 &
2045) II-21
Exhibit 4: World Diabetes Prevalence (2000-2019) II-22
Rise in CVD Incidence Spurs Demand II-22
Exhibit 5: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others II-23
Exhibit 6: Global Annual Medical Cost of CVD in US$ Billion
(2010-2030) II-23
Rising Cancer Incidence and Ensuing Rise in Critical Care
Admissions Create Need for Blood Gas and Electrolyte Analyzers II-24
Exhibit 7: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 II-24
Exhibit 8: Number of New Cancer Cases and Deaths (in Million)
by Region for 2018 II-25
Rise in Prevalence of COPD Augments Demand II-25
Exhibit 9: Global Prevalence of COPD by Age Group: Percentage
of Men and Women Affected by the Condition II-26
Rising Aging Population: Principal Driver for the BGA Market II-26
Exhibit 10: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050 II-27
Healthcare Cost-Cutting Trend Promotes Innovations II-27
Exhibit 11: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023 II-28

4. GLOBAL MARKET PERSPECTIVE II-29
Table 1: World Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 II-29

Table 2: World Historic Review for Blood Gas and Electrolyte
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 II-30

Table 3: World 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027 II-31

Table 4: World Current & Future Analysis for Portable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-32

Table 5: World Historic Review for Portable by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-33

Table 6: World 15-Year Perspective for Portable by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027 II-34

Table 7: World Current & Future Analysis for Benchtop by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-35

Table 8: World Historic Review for Benchtop by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-36

Table 9: World 15-Year Perspective for Benchtop by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027 II-37

Table 10: World Current & Future Analysis for Combined
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-38

Table 11: World Historic Review for Combined Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-39

Table 12: World 15-Year Perspective for Combined Analyzers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-40

Table 13: World Current & Future Analysis for Electrolyte
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-41

Table 14: World Historic Review for Electrolyte Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-42

Table 15: World 15-Year Perspective for Electrolyte Analyzers
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-43

Table 16: World Current & Future Analysis for Blood Gas
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-44

Table 17: World Historic Review for Blood Gas Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-45

Table 18: World 15-Year Perspective for Blood Gas Analyzers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-46

Table 19: World Current & Future Analysis for Clinical
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-47

Table 20: World Historic Review for Clinical Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-48

Table 21: World 15-Year Perspective for Clinical Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-49

Table 22: World Current & Future Analysis for Point of Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-50

Table 23: World Historic Review for Point of Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-51

Table 24: World 15-Year Perspective for Point of Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-52

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1
Table 25: USA Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-1

Table 26: USA Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-2

Table 27: USA 15-Year Perspective for Blood Gas and Electrolyte
Analyzers by Modality - Percentage Breakdown of Value Sales for
Portable and Benchtop for the Years 2012, 2020 & 2027 III-3

Table 28: USA Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-4

Table 29: USA Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-5

Table 30: USA 15-Year Perspective for Blood Gas and Electrolyte
Analyzers by Product - Percentage Breakdown of Value Sales for
Combined Analyzers, Electrolyte Analyzers and Blood Gas
Analyzers for the Years 2012, 2020 & 2027 III-6

Table 31: USA Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-7

Table 32: USA Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-8

Table 33: USA 15-Year Perspective for Blood Gas and Electrolyte
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Clinical Laboratories and Point of Care for the Years 2012,
2020 & 2027 III-9

CANADA III-10
Table 34: Canada Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-10

Table 35: Canada Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-11

Table 36: Canada 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012, 2020
& 2027 III-12

Table 37: Canada Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-13

Table 38: Canada Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-14

Table 39: Canada 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-15

Table 40: Canada Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-16

Table 41: Canada Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-17

Table 42: Canada 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-18

JAPAN III-19
Table 43: Japan Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-19

Table 44: Japan Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-20

Table 45: Japan 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012, 2020
& 2027 III-21

Table 46: Japan Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-22

Table 47: Japan Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-23

Table 48: Japan 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-24

Table 49: Japan Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-25

Table 50: Japan Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-26

Table 51: Japan 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-27

CHINA III-28
Table 52: China Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-28

Table 53: China Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-29

Table 54: China 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012, 2020
& 2027 III-30

Table 55: China Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-31

Table 56: China Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-32

Table 57: China 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-33

Table 58: China Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-34

Table 59: China Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-35

Table 60: China 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-36

EUROPE III-37
Table 61: Europe Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 III-37

Table 62: Europe Historic Review for Blood Gas and Electrolyte
Analyzers by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 III-38

Table 63: Europe 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 III-39

Table 64: Europe Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-40

Table 65: Europe Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-41

Table 66: Europe 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012,
2020 & 2027 III-42

Table 67: Europe Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-43

Table 68: Europe Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-44

Table 69: Europe 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-45

Table 70: Europe Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-46

Table 71: Europe Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-47

Table 72: Europe 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-48

FRANCE III-49
Table 73: France Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-49

Table 74: France Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-50

Table 75: France 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012,
2020 & 2027 III-51

Table 76: France Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-52

Table 77: France Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-53

Table 78: France 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-54

Table 79: France Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-55

Table 80: France Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-56

Table 81: France 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-57

GERMANY III-58
Table 82: Germany Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-58

Table 83: Germany Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-59

Table 84: Germany 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012,
2020 & 2027 III-60

Table 85: Germany Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-61

Table 86: Germany Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-62

Table 87: Germany 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-63

Table 88: Germany Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and
Point of Care - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-64

Table 89: Germany Historic Review for Blood Gas and Electrolyte
Analyzers by End-Use - Clinical Laboratories and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 III-65

Table 90: Germany 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by End-Use - Percentage Breakdown of
Value Sales for Clinical Laboratories and Point of Care for the
Years 2012, 2020 & 2027 III-66

ITALY III-67
Table 91: Italy Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Modality - Portable and Benchtop -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-67

Table 92: Italy Historic Review for Blood Gas and Electrolyte
Analyzers by Modality - Portable and Benchtop Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-68

Table 93: Italy 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Modality - Percentage Breakdown of
Value Sales for Portable and Benchtop for the Years 2012,
2020 & 2027 III-69

Table 94: Italy Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by Product - Combined Analyzers,
Electrolyte Analyzers and Blood Gas Analyzers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-70

Table 95: Italy Historic Review for Blood Gas and Electrolyte
Analyzers by Product - Combined Analyzers, Electrolyte
Analyzers and Blood Gas Analyzers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-71

Table 96: Italy 15-Year Perspective for Blood Gas and
Electrolyte Analyzers by Product - Percentage Breakdown of
Value Sales for Combined Analyzers, Electrolyte Analyzers and
Blood Gas Analyzers for the Years 2012, 2020 & 2027 III-72

Table 97: Italy Current & Future Analysis for Blood Gas and
Electrolyte Analyzers by End-Use - Clinical Laboratories and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817884/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: [email protected]  
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com